Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human Mesenchymal Stem Cell Conditioned Medium for Menopausal Disorders
jRCT1051260126Recruiting
- Sponsor
- Heiwa Clinic
- Start
- Apr 2024
- Countries
- 1
01
Overview
Open-label trial in menopause and Hypoandrogenism (TD) (2 arms), sponsored by Heiwa Clinic. Primary endpoints: Change in total testosterone (males), Change in free testosterone (males) and 4 more. Started Apr 2024; status: recruiting.
02
Conditions
menopauseHypoandrogenism (TD)
Beyond the preview
Go deeper on jRCT1051260126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051260126.